Luen-kui Chen

TPQ 11221, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Retraction Note: FK506-binding protein-5 in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease.

Retraction Note: FK506-binding protein-5 in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease.

Journal: Scientific reports

Published: September 03, 2026

Insulin increases expression of cannabinoid receptor 1 by suppressing lysosomal degradation via ERK signaling pathway.

Insulin increases expression of cannabinoid receptor 1 by suppressing lysosomal degradation via ERK signaling pathway.

Journal: International journal of medical sciences

Published: October 05, 2025

FK506-binding protein-5 in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease.

FK506-binding protein-5 in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease.

Journal: Scientific reports

Published: May 23, 2025

C-C chemokine receptor type 5 activation stimulates adipocyte differentiation through ERK-dependent pathway.

C-C chemokine receptor type 5 activation stimulates adipocyte differentiation through ERK-dependent pathway.

Journal: International journal of medical sciences

Published: April 10, 2025

Glucosamine induces hepatic FGF21 expression by activating the Akt/mTOR/p70S6K axis and driving PGC-1α activity.

Glucosamine induces hepatic FGF21 expression by activating the Akt/mTOR/p70S6K axis and driving PGC-1α activity.

Journal: Scientific reports

Published: December 31, 2024

Glucosamine inhibits myoblast proliferation and differentiation, and stimulates myotube atrophy through distinct signal pathways.

Glucosamine inhibits myoblast proliferation and differentiation, and stimulates myotube atrophy through distinct signal pathways.

Journal: The Journal of nutritional biochemistry

Published: May 28, 2024

Cysteine-cysteine Chemokine Receptor Type 5 Plays a Critical Role in Exercise Performance by Regulating Mitochondrial Content in Skeletal Muscle.

Cysteine-cysteine Chemokine Receptor Type 5 Plays a Critical Role in Exercise Performance by Regulating Mitochondrial Content in Skeletal Muscle.

Journal: Inflammation

Published: March 22, 2023

Nitric Oxide Mobilizes Intracellular Zn2+ via the GC/cGMP/PKG Signaling Pathway and Stimulates Adipocyte Differentiation.

Nitric Oxide Mobilizes Intracellular Zn2+ via the GC/cGMP/PKG Signaling Pathway and Stimulates Adipocyte Differentiation.

Journal: International journal of molecular sciences

Published: March 28, 2022

Cysteine-Cysteine Motif Chemokine Receptor 5 Expression in Letrozole-Induced Polycystic Ovary Syndrome Mice.

Cysteine-Cysteine Motif Chemokine Receptor 5 Expression in Letrozole-Induced Polycystic Ovary Syndrome Mice.

Journal: International journal of molecular sciences

Published: November 14, 2021

Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells.

Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells.

Journal: Frontiers in nutrition

Published: August 21, 2021

Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca2+/ERK/CaMKIII pathway in 3T3-L1 adipocytes.

Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca2+/ERK/CaMKIII pathway in 3T3-L1 adipocytes.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: June 12, 2021

Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome.

Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome.

Journal: Annals of neurology

Published: August 20, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026